Medplus Health Services Limited (NSE: MEDPLUS, BSE: 543427) is a Hyderabad, Telangana-based company in the Drug Stores and Pharmacies industry. With a market capitalisation of ₹7,352 Cr, it ranks #699 by market cap among the 6,137 Indian listed companies on FinBizNet. At ₹595.15 (as of 25 Oct 2026), the share price is 41.8% below its 52-week high of ₹1,022.20 and 3.3% above its 52-week low of ₹576.30. The share price is down 21.4% over one year and down 17.4% over three months.
| Current Price | ₹595.15 |
|---|---|
| Market Cap | ₹7,352 Cr |
| NSE Symbol | MEDPLUS |
| BSE Code | 543427 |
| Sector | Consumer Staples > Consumer Staples Distribution and Retail > Consumer Staples Distribution and Retail |
| Sub-Industry | Drug Retail > Drug Stores and Pharmacies |
| P/E Ratio | 32.6 |
| Return on Equity | 11.82% |
| Return on Assets | 5.86% |
| 52-Week Range | ₹576.30 – ₹1,022.20 |
| 1-Year Price Change | -21.4% |
| 3-Month Price Change | -17.4% |
| Beta (1Y) | 0.05 |
| Headquarters | Hyderabad, Telangana |
| Website | www.medplusindia.com |
| Revenue | ₹1,880 Cr |
|---|---|
| Net Profit | ₹33 Cr |
| Net Margin | 1.8% |
| EPS (Basic) | ₹2.76 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soaps, detergents, and sanitizers. The company also engages in wholesale cash and carry; provision of diagnostic, pathological, and laboratory testing services, as well as contract manufacturing of private-label pharmaceuticals, wellness products, and FMCG goods; and operates diagnostic centres. It distributes its products through retail and online channels. The company was incorporated in 2006 and is based in Hyderabad, India.
1. Wholesale-This segment engages in the wholesale cash and carry business. 2. Retail-This segment engages in the retail trading of medicines and general items. 3. Diagnostic Testing Services-This segment provides pathological testing services. 4. Unallocated-0
1. Retail-98.1% 2. Diagnostic Services-1.9% 3. Others-0%
Medplus Health Services Limited is trading at ₹595.15, with a market capitalisation of ₹7,352 Cr.
Medplus Health Services Limited operates in the Consumer Staples > Consumer Staples Distribution and Retail > Consumer Staples Distribution and Retail space (Drug Retail > Drug Stores and Pharmacies).
Medplus Health Services Limited has a P/E of 32.6 and a return on equity of 11.82%.
Medplus Health Services Limited is listed on the NSE under the symbol MEDPLUS and on the BSE under the scrip code 543427.
Medplus Health Services Limited's share price is down 21.4% over one year and down 17.4% over three months. Its 52-week range is ₹576.30 to ₹1,022.20.
In Q1 FY27, Medplus Health Services Limited reported revenue of ₹1,880 Cr and net profit of ₹33 Cr, with basic EPS of ₹2.76 (consolidated, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.